Abstract | BACKGROUND & OBJECTIVE: METHODS: RESULTS: Three patients had recurrence at 2, 10, and 12 months after operation individually in BCG group; no recurrence developed in combination group. The recurrence rate was significantly higher in BCG group than in combination group (14.28% vs. 0, P<0.05). No serious adverse events and complication developed in both groups. CONCLUSION:
|
Authors | Shan-Hong Yi, Gang Ye, Xiang-Wei Wang, Huan-Sheng Jin, Yuan-Ning Zhang, Zhi-Lin Yan |
Journal | Ai zheng = Aizheng = Chinese journal of cancer
(Ai Zheng)
Vol. 27
Issue 11
Pg. 1208-11
(Nov 2008)
China |
PMID | 19000455
(Publication Type: Evaluation Study, Journal Article)
|
Chemical References |
- Adjuvants, Immunologic
- Antineoplastic Agents, Phytogenic
- BCG Vaccine
- hydroxycamptothecinum
- Camptothecin
|
Topics |
- Adjuvants, Immunologic
(administration & dosage, adverse effects, therapeutic use)
- Administration, Intravesical
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Phytogenic
(administration & dosage, adverse effects, therapeutic use)
- BCG Vaccine
(administration & dosage, adverse effects, therapeutic use)
- Camptothecin
(administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
- Carcinoma, Transitional Cell
(drug therapy, surgery)
- Cystectomy
- Female
- Fever
(chemically induced)
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(prevention & control)
- Urinary Bladder Neoplasms
(drug therapy, surgery)
|